[Federal Register: February 7, 2005 (Volume 70, Number 24)]
[Notices]
[Page 6444-6445]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07fe05-79]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N-0031]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Premarket Notification for a New Dietary Ingredient
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the procedure by which a
manufacturer or distributor of dietary supplements or of a new dietary
ingredient is to submit information to FDA upon which it has based its
conclusion that a dietary supplement containing a new dietary
ingredient will reasonably be expected to be safe.
DATES: Submit written or electronic comments on the collection of
information by April 8, 2005.
ADDRESSES: Submit electronic comments on the collection of information
to: http://www.fda.gov/dockets/ecomments. Submit written comments on
the collection of information to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane., rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Peggy Robbins, Office of Management
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-1223.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Premarket Notification for a New Dietary Ingredient--21 CFR 190.6 (OMB
Control Number 0910-0330)--Extension
Section 413(a) of the Federal Food, Drug, and Cosmetic Act (the
act) (21 U.S.C. 350b(a)) provides that a manufacturer or distributor of
dietary supplements or of a new dietary ingredient is to submit
information to FDA (as delegate for the Secretary of Health and Human
Services) upon which it has based its conclusion that a dietary
supplement containing a new dietary ingredient will reasonably be
expected to be safe at least 75 days before the introduction or
delivery for introduction into interstate commerce of a dietary
supplement that contains a new dietary ingredient. FDA's regulations at
part 190, subpart B (21 CFR part 190, subpart B) implement these
statutory provisions. Section 190.6(a) requires each manufacturer or
distributor of a dietary supplement containing a new dietary
ingredient, or of a new dietary ingredient, to submit to the Office of
Nutritional Products, Labeling, and Dietary Supplements notification of
the basis for their conclusion that said supplement or ingredient will
reasonably be expected to be safe. Section 190.6(b) requires that the
notification include the following: (1) The complete name and address
of the manufacturer or distributor, (2) the name of the new dietary
ingredient, (3) a description of the dietary supplements that contain
the new dietary ingredient, and (4) the history of use or other
evidence of safety establishing that the dietary ingredient will
reasonably be expected to be safe.
The notification requirements described previously are designed to
enable FDA to monitor the introduction into the food supply of new
dietary ingredients and dietary supplements that contain new dietary
ingredients, in order to protect consumers from unsafe dietary
supplements. FDA uses the information collected under these regulations
to help ensure that a manufacturer or distributor of a dietary
[[Page 6445]]
supplement containing a new dietary ingredient is in full compliance
with the act.
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Annual Frequency Total Annual
21 CFR Section No. of Respondents per Response Responses Hours per Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
190.6 71 1 71 20 1,420
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
The agency believes that there will be minimal burden on the
industry to generate data to meet the requirements of the premarket
notification program because the agency is requesting only that
information that the manufacturer or distributor should already have
developed to satisfy itself that a dietary supplement containing a new
dietary ingredient is in full compliance with the act. However, the
agency estimates that extracting and summarizing the relevant
information from the company's files, and presenting it in a format
that will meet the requirements of section 413 of the act will require
a burden of approximately 20 hours of work per submission.
This estimate is based on the annual average number of premarket
notifications FDA received during the last 3 years (i.e., 2002 to
2004), which was 47. Forty-seven represents 24 more notifications than
the agency received as an annual average during the previous 3-year
period (i.e., 1999 to 2001). Therefore, FDA anticipates a similar
upward trend will be seen in the annual average number of notifications
the agency receives during 2005 to 2007, which is estimated to be 71.
Dated: January 28, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-2207 Filed 2-4-05; 8:45 am]
BILLING CODE 4160-01-S